In partnership with our Founding Sponsor, LabCentral 238 is excited to announce the next Astellas Speaker Series.
This session's topic will be Gene Therapy Research and CMC: Reflections for Building and Executing a Competitive Pipeline and will feature a presentation from Astellas Gene Therapies followed by a discussion with a diverse group of industry experts.
Please be sure to register today as space is limited!
In partnership with our Founding Sponsor, LabCentral 238 is excited to announce the next Astellas Speaker Series.
This session's topic will be Gene Therapy Research and CMC: Reflections for Building and Executing a Competitive Pipeline and will feature a presentation from the Astellas Gene Therapies followed by a discussion with a diverse group of industry experts.
Please be sure to register today as space is limited!
AGENDA
4:00 PM: Attendee Arrival & Registration
4:30 PM: Welcome Remarks from Hide Goto, President of AIRM, Astellas and Johannes Freuhauf, Co-Founder & CEO, LabCentral
4:35 PM: Introductory Presentation from Joe Laning, Executive Director, CMC, Astellas
5:00 PM: Expert Panel with Q&A
5:35 PM: Networking
4:00 PM: Attendee Arrival & Registration
4:30 PM: Welcome Remarks
4:35 PM: Introductory Presentation from Morten Sogaard
5:00 PM: Expert Panel with Q&A
5:35 PM: Networking
7:00 PM: Event Close
AGENDA
4:00 PM: Attendee Arrival & Registration
4:30 PM: Welcome Remarks
4:35 PM: Introductory Presentation from Morten Sogaard
5:00 PM: Expert Panel with Q&A
5:35 PM: Networking
FEATURED SPEAKER
FEATURED PANELISTS
Morten Sogaard
President
Gene Therapy Research & Technical Operations
Morten heads up Astellas Gene Therapy Research & Technical Operations based in South San Francisco. In this role reporting to the CSO of Astellas, Morten leads Astellas Gene Therapy & Technical Operations (RTO). In addition to Research and Technical Operations functions in California and Japan, his team also oversees construction and operation of thew new Astellas Research facility in South San Francisco along with IS, Compliance and other processes. Before that he headed up the Research function at Astellas Gene Therapies responsible for delivering ~ two clinical candidates per year.
Morten heads up Astellas Gene Therapy Research & Technical Operations based in South San Francisco. In this role reporting to the CSO of Astellas, Morten leads Astellas Gene Therapy & Technical Operations (RTO). In addition to Research and Technical Operations functions in California and Japan, his team also oversees construction and operation of thew new Astellas Research facility in South San Francisco along with IS, Compliance and other processes. Before that he headed up the Research function at Astellas Gene Therapies responsible for delivering ~ two clinical candidates per year.
THANK YOU TO OUR
FOUNDING SPONSOR
THANK YOU TO OUR
FOUNDING SPONSOR
